Endothelial dysfunction in heart failure with normal systolic function, and its correction with a metabolic agent, mildronate
To assess the influence of a metabolic agent, mildronate, on endothelial function in chronic heart failure (CHF) with normal systolic function, 105 patients with I-IIA Stage, II-III Functional Class (FC) CHF, and normal left ventricular systolic function, were examined. CHF developed as a result of...
Saved in:
| Main Authors: | V. P. Geychenko, A. V. Kuryata, O. V. Muzhchil |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2005-08-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2403 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MILDRONATE POTENTIAL FOR CORRECTING COGNITIVE DYSFUNCTION IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
by: M. E. Statsenko, et al.
Published: (2011-08-01) -
ENDOTHELIAL DYSFUNCTION AND ITS CORRECTION WIT CYTOPROTECTORS IN PATIENTS WITH STABLE EFFORT ANGINA AND ARTERIAL HYPERTENSION
by: F. E. Khlebodarov, et al.
Published: (2009-12-01) -
Mildronate in cardiology practice – current evidence, ongoing research, and future perspectives
by: V. P. Mikhin, et al.
Published: (2012-02-01) -
MILDRONATE EFFECT ON ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH CHRONIC HEART FAILURE: DOUBLE BLIND CROSSOVER STUDY
by: L. G. Voronkov, et al.
Published: (2016-01-01) -
INFLUENCE OF MILDRONATE ON EFFICIENCY OF ANTIANGINAL THERAPY IN PATIENTS WITH STABLE BURDEN ANGINA
by: N. P. Kutishenko, et al.
Published: (2015-12-01)